Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,752 | -90,195 | -37,138 | -29,723 | N/A |
| Depreciation Amortization | -2,053 | 258 | 109 | 35 | N/A |
| Accounts receivable | 50 | 7 | -1,086 | N/A | N/A |
| Accounts payable and accrued liabilities | -307 | 103 | -480 | 591 | N/A |
| Other Working Capital | -1,176 | 12,817 | -1,327 | -334 | N/A |
| Other Operating Activity | 21,984 | 13,505 | 11,904 | 9,234 | 0 |
| Operating Cash Flow | $-123,254 | $-63,505 | $-28,018 | $-20,197 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -401,076 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,703 | -1,136 | -204 | -279 | N/A |
| Other Investing Activity | 0 | 0 | -859 | 8,212 | 0 |
| Investing Cash Flow | $-403,779 | $-1,136 | $-1,063 | $7,933 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 7,338 | N/A | N/A |
| Debt Repayment | N/A | -7,963 | N/A | N/A | N/A |
| Common Stock Issued | 595,094 | 219,165 | 197 | 38 | N/A |
| Other Financing Activity | -32,892 | 56,492 | 72,351 | 9,717 | 0 |
| Financing Cash Flow | $562,202 | $267,694 | $79,886 | $9,755 | $N/A |
| Beginning Cash Position | 257,254 | 54,201 | 8,371 | 10,880 | N/A |
| End Cash Position | 292,423 | 257,254 | 59,176 | 8,371 | N/A |
| Net Cash Flow | $35,169 | $203,053 | $50,805 | $-2,509 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,254 | -63,505 | -28,018 | -20,197 | N/A |
| Capital Expenditure | -2,703 | -1,136 | -204 | -279 | N/A |
| Free Cash Flow | -125,957 | -64,641 | -28,222 | -20,476 | 0 |